在美国监狱系统中对左心室辅助装置治疗的考虑
Peter M Eckman1, Navin Rajagopalan2, Joan Henriksen3
1Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota.
Journal of cardiac failure
|August 9, 2023
概括
监禁不应该阻止患有晚期心力衰竭的患者接受左心室辅助器件 (LVAD) 治疗. 本研究探讨了在惩戒系统内管理LVAD患者的实际考虑.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 医学伦理 医学伦理
背景情况:
- 晚期心力衰竭需要先进的治疗方法,如左心室辅助装置 (LVAD) 植入.
- 目前的指导方针和法律解释表明,由于潜在的患者限制,监禁可能是LVAD治疗的禁忌.
- 国际标准和美国法律先例规定,监禁人员的医疗保健与社区中的医疗保健相似.
研究的目的:
- 挑战监禁是LVAD治疗绝对禁忌的概念.
- 为心力衰竭项目提供实用考虑,管理被监禁或可能被监禁的患者.
- 倡导继续为符合条件的患者提供LVAD治疗机会,无论他们的纠正状态如何.
主要方法:
- 一个先进的心力衰竭患者的案例研究介绍,需要在校正环境中接受LVAD治疗.
- 讨论将LVAD护理与惩戒卫生系统相结合的实际挑战和解决方案.
- 审查有关国际和美国有关监禁人口医疗护理的指导方针.
主要成果:
- 在监禁患者中,当校正卫生系统和先进的心力衰竭计划有效合作时,可以成功管理LVAD治疗.
- 解决法律,后勤和道德方面的考虑对于在这个人群中实施LVAD治疗至关重要.
- 通过积极的合作伙伴关系和遵守既定医疗标准,可以优化患者护理和结果.
结论:
- 监禁不应该自动取消高级心力衰竭患者接受拯救生命的LVAD治疗的资格.
- 心力衰竭团队与惩戒卫生服务之间的合作对于成功管理至关重要.
- 需要进一步的对话和政策制定,以确保所有患者平等获得先进的心脏支持.
相关概念视频
01:29Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:30Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13